Northwest Biotherapeutics
OTC: NWBOBethesda, US · Delaware corporation · 1 known investors
Biotechnology company developing and commercializing immunotherapy products for cancer
Biotech
Founders & leadership
LF
Linda F PowersExecutive Officer, Director
NM
Navid MalikDirector
MB
Marnix BoschExecutive Officer
JJ
Jerry JasinowskiDirector
LG
Leslie GoldmanExecutive Officer
JC
J Cofer BlackDirector
AB
Alton BoyntonExecutive Officer, Director
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$2.6MofferedSep 2020 · 2 investors · PharmaceuticalsRule 506(b)
▶$2.6MofferedSep 2020 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Jerry J JasinowskiDirector
- Leslie J GoldmanExecutive Officer
- J Cofer BlackDirector
- Navid MalikDirector
- Alton BoyntonExecutive Officer, Director
- Marnix L BoschExecutive Officer
- Linda F PowersExecutive Officer, Director
- Offering amount
- $2.6M
- First sale
- Aug 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$880KraisedJan 2018 · BiotechnologyRule 506(c)
▶$880KraisedJan 2018 · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Linda F PowersExecutive Officer, Director
- Navid MalikDirector
- Marnix BoschExecutive Officer
- Jerry JasinowskiDirector
- Leslie GoldmanExecutive Officer
- J Cofer BlackDirector
- Alton L BoyntonExecutive Officer, Director
- Amount sold
- $880K
- Minimum investment
- $10K
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06c
▶$52KraisedMay 2017 · 1 investors · BiotechnologyRule 506(b)
▶$52KraisedMay 2017 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- J Cofer BlackDirector
- Robert A FarmerDirector
- Jerry JasinowskiDirector
- Navid MalikDirector
- Leslie GoldmanExecutive Officer
- Alton L BoyntonExecutive Officer, Director
- Linda F PowersExecutive Officer, Director
- Amount sold
- $52K
- First sale
- May 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10MraisedMar 2016 · 5 investors · BiotechnologyRule 506(b)
▶$10MraisedMar 2016 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Cofer BlackDirector
- Navid MalikDirector
- Alton L. BoyntonExecutive Officer, Director
- Susan BayhDirector
- Linda F. PowersExecutive Officer, Director
- Jerry JasinowskiDirector
- Robert A. FarmerDirector
- Offering amount
- $10M
- Amount sold
- $10M
- Minimum investment
- $595.4K
- Sales commissions
- $700K
- Placement agents
- H.C. Wainwright
- First sale
- Feb 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.